Clinical trial
Effects of Linagliptin on Renal Endothelium Function in Patients With Type 2 Diabetes.
NCT01835678
Study timeline
Study start (unknown)2012-10-01Date precision: month
Registry last updated2018-01-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2-diabetesunresolved
Interventions
LinagliptinDRUG · verified · RxNorm: linagliptin
PlaceboDRUG
Sponsors & collaborators
University of Erlangen-Nürnberg Medical Schoollead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01835678 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.